Search
for
Sort by
Research 61–90 of 1000+
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Down‐regulation of Shh in the hair follicles of mice during chemotherapy‐induced hair loss is mediated by the JAK / STAT1 signaling pathway
- JAK Inhibitors in Down Syndrome: Alopecia Areata Resolution and Vitiligo Improvement with Baricitinib
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- BH19 ‘JAK in the box?’ Long-term safety concerns with oral Janus kinase inhibitors for alopecia areata
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- 84 Partial restoration of scalp microbiota in alopecia areata with JAK inhibitors
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- Observation and consideration on using of JAKi in clinical trials in times of COVID ‐19
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- Real‐World Outcomes and Safety of JAK Inhibitors in Paediatric Alopecia Areata: A Retrospective Multicentre Study
- When hair dig into the brain, JAKi , may help!
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- 77200 Infections and Therapy Lapses Predominate as Flare Triggers on Oral JAK Inhibitors for Alopecia Areata: A Retrospective Cohort Study
- 73571 The real-world impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM
- JAK-STAT pathway-associated skin diseases: a refined functional framework for inflammatory skin diseases
- Janus Kinase (JAK) Inhibitors in Dermatology: An Update and Critical Review
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- Multiomic Characterization of Treatment Response to JAK Inhibition in Patients with APECED
- JAK Inhibitors in the Treatment of Alopecia Areata: Efficacy, Safety, and Long-term Outcomes